Literature DB >> 32053158

Missing Panels in Figure 1.

.   

Abstract

Year:  2020        PMID： 32053158      PMCID： PMC8177384          DOI： 10.1001/jamaoncol.2019.6910

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries.

Authors:  Steven T Bird; Fang Tian; Natasha Flowers; Donna Przepiorka; Rongrong Wang; Tae-Hyun Jung; Zebulin Kessler; Corinne Woods; Bo Kim; Barry W Miller; Michael Wernecke; Clara Kim; Stephen McKean; Kate Gelperin; Thomas E MaCurdy; Jeffrey A Kelman; David J Graham
Journal:  JAMA Oncol       Date:  2020-02-01       Impact factor: 31.777
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.